Synonyms: ALN-57213 | ALN-AT3 | ALN-AT3SC
Compound class:
Nucleic acid
Comment: Fitusiran is a small interference RNA (siRNA) class agent. It is intended to reduce the antithrombin (SERPINC1) protein level as a mechanism to promote thrombin synthesis and rebalance hemostasis (and prevent bleeds) in patients with hemophilia A or B [4-5].
GalNAc-conjugation is a strategy used to promote delivery of the drug to the liver [2]- this is annotated as 'R1' in the sequence provided here. We have been unable to locate a full chemical SMILES for the ligand, or its HELM notation. |
Classification ![]() |
|
Compound class | Nucleic acid |
Compound subclass | siRNA |
Target | antithrombin (SERPINC1) mRNA |
International Nonproprietary Names ![]() |
|
INN number | INN |
10177 | fitusiran |
Synonyms ![]() |
ALN-57213 | ALN-AT3 | ALN-AT3SC |
Database Links ![]() |
|
CAS Registry No. | 1499251-18-1 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL4297754 |
DrugBank Ligand | DB15002 |
GtoPdb PubChem SID | 504705449 |
Search PubMed clinical trials | fitusiran |
Search PubMed titles | fitusiran |
Search PubMed titles/abstracts | fitusiran |